Hailey-Hailey Disease (Familial Benign Pemphigus)

  • Carmen Maria Salavastru
  • George-Sorin TiplicaEmail author


Hailey-Hailey disease is a rare autosomal dominant genetic disease due to mutations in the ATP2C1 gene. The defective gene induces the production of altered desmosomal components in the Golgi apparatus. The clinical diagnosis of Hailey-Hailey disease is based on the recurrent erythematous plaques with vesicles and fissures that occurred symmetrically in flexural areas. The lesions can become hypertrophic and malodorous. The histopathological elements are characteristic: acantholytic vesicles and a “dilapidated brick wall” structure of the epidermis. Hailey-Hailey disease has no specific treatment, and the patients have a poor quality of life. Local and systemic treatment includes antibiotics, antifungals and corticosteroids. Other treatments include: botulinum toxin injections, retinoids and laser CO2 ablation.


Hailey-Hailey disease Blister ATP2C1 gene Acantholysis 

Further Reading

  1. Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992;126(3):275–82.CrossRefGoogle Scholar
  2. Heinze R. Chronic benign familial pemphigus (Gougerot-Hailey-Hailey) with mucosal involvement in a diabetic. Dermatol Monatsschr. 1979;165(12):862–7 [German].PubMedGoogle Scholar
  3. Hovnanian A. Chapter 49. Acantholytic disorders of the skin: Darier-White disease, acrokeratosis verruciformis, grover disease, and Hailey-Hailey disease. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York: McGraw Hill Medical; 2008. p. 438–42.Google Scholar
  4. Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, Ikeda S, Mauro T, Epstein Jr EH. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000;24(1):61–5.CrossRefGoogle Scholar
  5. Hwang LY, Lee JB, Richard G, Uitto JJ, Hsu S. Type 1 segmental manifestation of Hailey-Hailey disease. J Am Acad Dermatol. 2003;49(4):712–4.CrossRefGoogle Scholar
  6. Johnson Jr BL, Yan AC. Chapter 6. Congenital diseases (Genodermatoses). In Elder DE, Elenitsas R, et al., editors. Lever’s histopathology of the skin. 10th ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer Business; 2009. p. 148–9.Google Scholar
  7. Missiaen L, Raeymaekers L, Dode L, Vanoevelen J, Van Baelen K, Parys JB, Callewaert G, De Smedt H, Segaert S, Wuytack F. SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun. 2004;322(4):1204–13.CrossRefGoogle Scholar
  8. Pîrvu A, Ruşinoiu A, Panduru M, Constantin MM, Sălăvăstru C, Ţiplica GS, Costache M. Boala Hailey-Hailey. Dermatovenerologia. 2007;52(s1):23. nr. 2, [Romanian].Google Scholar
  9. Poblete-Gutiérrez P, Wiederholt T, König A, Jugert FK, Marquardt Y, Rübben A, Merk HF, Happle R, Frank J. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest. 2004;114(10):1467–74.CrossRefGoogle Scholar
  10. Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, Healy E, Dissanayake M, Larrègue M, Perrussel M, Lehrach H, Munro CS, Strachan T, Burge S, Hovnanian A, Monaco AP. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000;9(7):1131–40.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Carmen Maria Salavastru
    • 1
  • George-Sorin Tiplica
    • 1
    Email author
  1. 1.2nd Clinic of DermatologyColentina Clinical Hospital – “Carol Davila” University of Medicine and PharmacyBucharestRomania

Personalised recommendations